Michael J. Dooley BPharm, GradDipHospPharm, PhD, FSHP, AdvPracPharm
{"title":"Vale Amy McRae","authors":"Michael J. Dooley BPharm, GradDipHospPharm, PhD, FSHP, AdvPracPharm","doi":"10.1002/jppr.1879","DOIUrl":null,"url":null,"abstract":"<p>This issue of the <i>Journal</i> includes a paper titled ‘Time for change: Improving neuromuscular blocking agent safety in Australia’.<span><sup>1</sup></span> The lead author, Amy McRae, sadly passed away last year on 15 December, at home peacefully with her family by her side.</p><p>Amy had a passion and determination to improve the safe use of medicines and this influenced the many pharmacists, nurses, doctors, and patients who had the pleasure of interacting with her during her career. This included in her early role as a clinical pharmacist, through to more recently as Senior Medication Safety Pharmacist at Alfred Health. In addition, Amy was also the Senior Pharmacist, Quality Use of Medicines, Western Health and Senior Lecturer, Post-Graduate Studies and Professional Development Unit, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University.</p><p>Her contribution to improving the care of patients and reducing the risks associated with medication will be one of her many legacies. Amy was central in Australia-wide improvements to reduce neuromuscular blocking agent (NMBA) administration errors, which can cause unintended paralysis, respiratory arrest, severe permanent harm, and death. These endeavours included the publication of a national report <i>Time for change: proposed improvements to the labelling and packaging of neuromuscular blocking agents in Australia</i>.<span><sup>2</sup></span> This work, supported by the Victorian Therapeutics Advisory Group and many other national organisations, resulted in the introduction of mandatory warning statements for the labels of NMBAs in Australia. Amy was also pivotal in a range of other initiatives, including reducing potentially fatal errors associated with high doses of insulin, the introduction of Tall Man lettering to reduce medication selection errors, and patient education and empowerment strategies to improve prophylaxis for venous thromboembolism.</p><p>We are very saddened that Amy is not here to share in this milestone but know that her impact and legacy will continue. Amy was a wonderful person whose courage and determination to live a full life was inspirational to many of us who knew her. Amy will continue to be missed by many and her impact on making care safer will be felt far into the future.</p><p>The author complies with the <i>Journal's</i> authorship policy.</p><p>Michael Dooley is the Editor-in-Chief of the <i>Journal of Pharmacy Practice and Research</i>.</p><p>Ethics approval was not required for this announcement.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2023-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1879","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1879","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
This issue of the Journal includes a paper titled ‘Time for change: Improving neuromuscular blocking agent safety in Australia’.1 The lead author, Amy McRae, sadly passed away last year on 15 December, at home peacefully with her family by her side.
Amy had a passion and determination to improve the safe use of medicines and this influenced the many pharmacists, nurses, doctors, and patients who had the pleasure of interacting with her during her career. This included in her early role as a clinical pharmacist, through to more recently as Senior Medication Safety Pharmacist at Alfred Health. In addition, Amy was also the Senior Pharmacist, Quality Use of Medicines, Western Health and Senior Lecturer, Post-Graduate Studies and Professional Development Unit, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University.
Her contribution to improving the care of patients and reducing the risks associated with medication will be one of her many legacies. Amy was central in Australia-wide improvements to reduce neuromuscular blocking agent (NMBA) administration errors, which can cause unintended paralysis, respiratory arrest, severe permanent harm, and death. These endeavours included the publication of a national report Time for change: proposed improvements to the labelling and packaging of neuromuscular blocking agents in Australia.2 This work, supported by the Victorian Therapeutics Advisory Group and many other national organisations, resulted in the introduction of mandatory warning statements for the labels of NMBAs in Australia. Amy was also pivotal in a range of other initiatives, including reducing potentially fatal errors associated with high doses of insulin, the introduction of Tall Man lettering to reduce medication selection errors, and patient education and empowerment strategies to improve prophylaxis for venous thromboembolism.
We are very saddened that Amy is not here to share in this milestone but know that her impact and legacy will continue. Amy was a wonderful person whose courage and determination to live a full life was inspirational to many of us who knew her. Amy will continue to be missed by many and her impact on making care safer will be felt far into the future.
The author complies with the Journal's authorship policy.
Michael Dooley is the Editor-in-Chief of the Journal of Pharmacy Practice and Research.
Ethics approval was not required for this announcement.
期刊介绍：
The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
